HEAL Pain Partnering Meeting

Virtual Event
Free and Open Registration
This event will take place each day at 11:00 a.m. – 5:00 p.m. ET

A major focus of the HEAL initiative is the discovery and development of new treatments for pain. This meeting will convene investigators, members of industry, private funders, and NIH staff to address challenges within the commercial landscape of pain therapeutics, and to create connections between HEAL-funded investigators and potential partners.

• Address critical challenges within the commercialization landscape for pain
• Showcase HEAL-funded investigators working to develop treatments for pain
• Connect HEAL-funded investigators with potential partners

Meredith Fisher, Ph.D., Partner, Mass General Brigham Ventures

Eric Nisenbaum, Ph.D., Senior Vice President, Head Boston Innovation Hub, Grünenthal Group

All times posted are in Eastern Daylight Time.

Wednesday October 4^th, 2023
Day 1: Exploring the pain therapy development landscape

11:00 am — Welcoming Remarks
Dr. Eric Nisenbaum, Senior Vice President, Head Boston Innovation Hub, Grünenthal Group

11:10 am — Introduction to HEAL
Dr. Rebecca Baker, Director, HEAL Initiative

11:30 am — Keynote
Christin Veasley, Co-Founder and Director, Chronic Pain Research Alliance

12:15 pm — Lunch Break

12:45 pm — Industry Panel on Pain Therapeutics Development
Moderator: Dr. Eric Nisenbaum, Senior Vice President, Head Boston Innovation Hub, Grünenthal Group

Panelists:

• Dr. Gillian Burgess, Executive Vice President, Head of Research, Grünenthal
• Dr. Amy Chappell, Strategist in Neuroscience Drug Development and Board Member
• Dr. Kelly Knopp, Vice President, Pain and Neuronal Health, Eli Lilly

1:45 pm — Investor Panel on Pain Therapeutics Development
Moderator: Dr. Meredith Fisher, Partner, Mass General Brigham Ventures

Panelists:

• Dr. Jasmina Marjanovic, Partner Takeda Ventures Inc.
• Doug Crawford, Managing Partner, Mission BioCapital
• Jamil Beg, Partner, 5 am Ventures

2:45 pm — Break

3:00 pm — HEAL Pain Therapeutic Development Programs

• Dr. Steven Pittenger, HEAL Program Director, NCATS
• Dr. Julia Bachman, HEAL Program Director, NINDS
• Dr. Matthew Hall, HEAL Program Director, NCATS
• Dr. Ram Arudchandran, HEAL Program Director, NINDS
• Dr. Smriti Iyengar, HEAL Program Director, NINDS
• Dr. Emily Caporello, HEAL Program Director, NINDS
• Dr. Mary Ann Pelleymounter, HEAL Program Director, NINDS
• Dr. Barbara Karp, HEAL Program Director, NINDS

4:00 pm — Open Discussion on Gaps and Opportunities in the Pain Therapy Development Pipeline
Moderator: Dr. Amir Tamiz, Director, Division of Translational Research, NINDS

Panelists:

• Dr. Meredith Fisher, Partner, Mass General Brigham Ventures
• Dr. Eric Nisenbaum, Senior Vice President, Head Boston Innovation Hub, Grünenthal Group
• Dr. Mary Ann Pelleymounter, Program Director, NIH HEAL Pain Therapeutics Development Program

4:45 pm — Closing Remarks
Dr. Walter Koroshetz, Director, NINDS

5:00 pm — Adjourn
Dr. Steven Pittenger, HEAL Program Director, NCATS

Thursday October 5^th, 2023
Day 2: The future of pain therapeutics featuring HEAL-funded early-stage companies

11:00 am — Welcoming Remarks
Dr. Meredith Fisher, Partner, Mass General Brigham Ventures

11:05 am — Pitch Competition Overview
Sara Dauber, Strategic Consultant, NINDS

11:15 am — Pitch Competition Session 1
HEAL-Supported Companies

12:45 pm — Lunch Break

1:15 pm — Pitch Competition Session 2
HEAL-Supported Companies

2:45 pm — Break for Deliberation

3:00 pm — Announce winner(s) and present themes from deliberation
Dr. Meredith Fisher, Partner, Mass General Brigham Ventures

3:20 pm — Closing Remarks
Dr. Christine Colvis, HEAL Preclinical and Translational Working Group Co-Lead, NCATS

3:30 pm — Adjourn
Dr. Steven Pittenger, HEAL Program Director, NCATS

Emily Caporello, Ph.D., at [email protected]

Steven Pittenger, Ph.D., at [email protected]